Retrospective study on sugammadex for reversal of neuromuscular blockade after radiofrequency ablation of hepatic carcinoma under general anesthesia
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 1
Abstract
[Objective] To investigate the effect of sugammadex for reversal of neuromuscular blockade postoperatively in the patients with CT guided radiofrequency ablation of hepatic carcinoma under general anesthesia. [Methods] The clinical data of 220 patients with radiofrequency ablation of hepatic carcinoma under general anesthesia from November 2019 to February 2022 in our hospital were retrospectively analyzed. Patients were divided into sugammadex group (group S) with 108 patients and neostigmine group (group N) with 112 patients based on choice of neuromuscular blockade reversal. All was by intravenous anesthesia in two groups with same anesthesia induction and maintenance. Group S received intravenous sugammadex 2 mg/kg at the end of the surgery and group N neostigmine 2 mg combined with atropine 0.5-1.0 mg. Time to spontaneous breathing, time of tracheal extubation, period of postanesthesia care unit(PACU) stay and postoperative hospital stay between 2 groups were compared combined with rate of atelectasis examined by CT scan within 10 min after extubation, liver function 24 h postoperatively and pulmonary complication. [Results] The time to spontaneous breathing, time of extubation, and period of PACU stay in group S decreased significantly compared with those in group N (P<0.05). Both rate of atelectasis [35 (32.4%) vs. 59 (52.7%)]within 10 min after extubation and rate of pulmonary complication [4 (3.7%) vs. 11 (9.8%)] postoperatively decreased (all P<0.05). The liver function 24 h postoperatively in both groups was significantly higher than those before operation (P<0.05) without significant difference between two groups (P>0.05). [Conclusions] Sugammadex could reverse neuromuscular blockade more quickly and lowering the rates of early postoperative atelectasis and pulmonary complication of the patients with hepatic radiofrequency ablation.
Authors and Affiliations
Hui ZHANG, Ling GONG, Qian GUO, Yan LUO
Keywords
Related Articles
- EP ID EP750848
- DOI 10.16139/j.1007-9610.2023.01.12
- Views 26
- Downloads 0
<![CDATA[Application of 21-Gene test in adjuvant radiotherapy for early breast cancer]]>
<![CDATA[Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of pe...
Gastric signet ring cell carcinoma: clinicopathology and surgical treatment combined with comprehensive therapy
Classification and surgical treatment of congential biliary dilatation
Congential biliary dilitation (CBD) is rare biliary tract disease in clinic. Clinical classification and disease characteristics of CBD is the key of accurate treatment. Surgical treatment was regarded as the first choic...
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in treatment of peritoneal metastatic gastric cancer: current status and future prospects
Prognostic analysis of the patients with HER2-positive breast cancer adjuvant treated with trastuzumab: a report of 1 246 cases
[Objective] To analyze the prognostic factors in the patients with HER2-positive breast cancer adjuvant treated with trastuzumab. [Methods] We conducted a retrospective analysis of clinical data of 1 246 patients diagnos...